TY - JOUR
T1 - Buforin II bacteria agglutination activity as part of its antimicrobial action mechanism
AU - Munoz-Camargo, Carolina
AU - Montoya, Vivian Salazar
AU - Barrero-Guevara, Laura Andrea
AU - Groot, Helena
AU - Boix, Ester
N1 - Funding Information:
The need for new antimicrobial agents has endorsed the search for new antimicrobial peptides, and moreover, it increased the number of studies focusing on their action mechanisms [26]. In consequence, different studies showed that antimicrobial peptides can target the cell's membrane using a wide and diverse repertoire of modes of action, while others can disrupt key processes inside the cell [13], [14], [27]. Buforin II is one the most recurrent examples of peptides with an intracellular action mechanism. Nonetheless, as peptides can use more than one action mechanism, we assessed other potential capacities of Buforin II. With this purpose, we confirmed Buforin II antibacterial activity against E. coli as well as its already reported action mechanism and for the first time, weeprort BuforinIIgaglutinationcatityi.v ACKNOWLEDGMENTS The research was funded by the Fundación Bolívar Davivienda and the Programa Francisco José de Caldas of Colciencias (Convocatoria 497 de 2009), as well as the Proyecto Semilla of Department of Biological Sciences, Convocatoria Producto Terminado of Vicerrectoría de Investigación and the Department of Biomedical Engineering of Universidad de Los Andes. This study was also partially supported by the Ministerio de Economía y Competitividad (SAF2015-66007-P grant) cofinanced by FEDER funds to EB (Dpt. Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Spain).
Publisher Copyright:
© 2018 IEEE.
PY - 2018/9/18
Y1 - 2018/9/18
N2 - Antimicrobial peptides (AMPs) have been found in many multicellular organisms and are considered part of their innate immune system. Several AMP action mechanisms have been described, but recent studies have proposed that a single peptide can use multiple of them. Here we confirm the Buforin II action mechanism already reported and evaluate its capacity to induce bacterial agglutination as part of its action mechanism repertoire. With this purpose, we evaluated and confirmed Buforin II antibacterial activity against Escherichia coli, confirmed its action mechanism in the bacteria and in a membrane model using large unilamellar vesicles (LUVs) and further assessed the peptide agglutination capacity in these two models. Our results show, that Buforin II antibacterial activity against E. coli is accomplished without membrane permeabilization or polarization as reported in previous studies. Furthermore, we report for the first time that Buforin II induces bacteria and LUV agglutination. Hence, here we confirm Buforin II antibacterial action mechanism and describe the bacteria agglutination activity of the peptide.
AB - Antimicrobial peptides (AMPs) have been found in many multicellular organisms and are considered part of their innate immune system. Several AMP action mechanisms have been described, but recent studies have proposed that a single peptide can use multiple of them. Here we confirm the Buforin II action mechanism already reported and evaluate its capacity to induce bacterial agglutination as part of its action mechanism repertoire. With this purpose, we evaluated and confirmed Buforin II antibacterial activity against Escherichia coli, confirmed its action mechanism in the bacteria and in a membrane model using large unilamellar vesicles (LUVs) and further assessed the peptide agglutination capacity in these two models. Our results show, that Buforin II antibacterial activity against E. coli is accomplished without membrane permeabilization or polarization as reported in previous studies. Furthermore, we report for the first time that Buforin II induces bacteria and LUV agglutination. Hence, here we confirm Buforin II antibacterial action mechanism and describe the bacteria agglutination activity of the peptide.
KW - Antimicrobial Peptides
KW - Escherichia coli
KW - Histone-derived Peptides
KW - Host Defense Peptides
UR - https://www.scopus.com/pages/publications/85055470112
U2 - 10.1109/SIB.2018.8467743
DO - 10.1109/SIB.2018.8467743
M3 - Article
AN - SCOPUS:85055470112
JO - 2018 9th International Seminar of Biomedical Engineering, SIB 2018 - Conference Proceedings
JF - 2018 9th International Seminar of Biomedical Engineering, SIB 2018 - Conference Proceedings
ER -